WASHINGTON (Reuters) – U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai’s office said.
Tai and Moderna Chief Executive Stephane Bancel also discussed increasing vaccine production and global health issues, Tai’s office said in a statement.
(Reporting by Jason Lange; Editing by Mohammad Zargham)
